Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles.

scientific article published on 25 November 2011

Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BIOMATERIALS.2011.11.012
P698PubMed publication ID22118775

P2093author name stringYan Wu
Wei Li
Qing Xu
Chunying Chen
Yuexian Liu
Shishuai Su
P433issue5
P921main subjectnanoparticleQ61231
paclitaxelQ423762
P304page(s)1627-1639
P577publication date2011-11-25
P1433published inBiomaterialsQ15751139
P1476titleAnti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles.
P478volume33

Reverse relations

cites work (P2860)
Q57273266A dual-targeting nanocarrier based on modified chitosan micelles for tumor imaging and therapy
Q36949458A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms
Q38733989A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours
Q51022530Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
Q41709059Application of dual targeting drug delivery system for the improvement of anti-glioma efficacy of doxorubicin
Q38690361Can dual-ligand targeting enhance cellular uptake of nanoparticles?
Q34119423Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes
Q38067265Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.
Q54946110Determining the Radiation Enhancement Effects of Gold Nanoparticles in Cells in a Combined Treatment with Cisplatin and Radiation at Therapeutic Megavoltage Energies.
Q36235151Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting
Q34416829Dual-targeting delivery system for bone cancer: synthesis and preliminary biological evaluation
Q61445440Efficient siRNA delivery and gene silencing using a lipopolypeptide hybrid vector mediated by a caveolae-mediated and temperature-dependent endocytic pathway
Q39233880Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery
Q61811756Enhanced Anti-tumor of Pep-1 Modified Superparamagnetic Iron Oxide/PTX Loaded Polymer Nanoparticles
Q37682915Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
Q37168978Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line.
Q41665088Hyperbranched polymer drug delivery treatment for lung metastasis of salivary adenoid cystic carcinoma in nude mice
Q38764815Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles
Q39273796In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors
Q28391849Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Q50917286Iodine-131-labeled, transferrin-capped polypyrrole nanoparticles for tumor-targeted synergistic photothermal-radioisotope therapy.
Q38568248Multiscale approach to investigate self-assembly of telodendrimer based nanocarriers for anticancer drug delivery.
Q38093458Nano-bio effects: interaction of nanomaterials with cells
Q26801067Nanotechnology: Future of Oncotherapy
Q38054112Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity
Q39036547Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery
Q52646682Peptide Mediated In Vivo Tumor Targeting of Nanoparticles through Optimization in Single and Multilayer In Vitro Cell Models.
Q38248809Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles
Q47621457Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy
Q26740580Progress and perspectives on targeting nanoparticles for brain drug delivery.
Q51017351RGD Peptide-Pegylated PLLA Nanoparticles Containing Epirubicin Hydrochloride Exhibit Receptor-Dependent Tumor Trafficking In Vitro and In Vivo.
Q38204933Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy
Q38084739Receptor-based targeting of therapeutics.
Q38116765Targeted delivery of nano-therapeutics for major disorders of the central nervous system.
Q43564347The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy
Q37091818The functions and applications of RGD in tumor therapy and tissue engineering
Q38071901The holistic 3M modality of drug delivery nanosystems for cancer therapy
Q35816600The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo.
Q94525640Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy
Q48485535Transferrin conjugated nontoxic carbon dots for doxorubicin delivery to target pediatric brain tumor cells.
Q38787524Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics
Q53563682Triple Redox Responsive Poly(Ethylene Glycol)-Polycaprolactone Polymeric Nanocarriers for Fine-Controlled Drug Release.
Q38134759Tumor Targeting via Integrin Ligands
Q37252208Ultrabright and multicolorful fluorescence of amphiphilic polyethyleneimine polymer dots for efficiently combined imaging and therapy

Search more.